Mission

To make all who are touched by invasive lobular breast cancer (also referred to as invasive lobular carcinoma or “ILC”) aware of its unique characteristics and the critical need for more ILC research; to be the go-to source for information on ILC studies, clinical trials and educational tools; to foster partnerships among patients, scientists, clinicians, and breast cancer organizations to increase dialogue about ILC and research advocacy; and to fund vital ILC research. We envision a world in which lobular breast cancer is found early, treated effectively, and eradicated permanently.